|
EUCAST vs CLSI, Antifungal susceptibility testing (click for details) |
|
|
|
Pharmacodynamics of Posaconazole in a Neutropenic Animal Model of Invasive
Pulmonary Aspergillosis (click for details) |
|
|
|
Misidentification of the emerging pathogenic yeast species Candida nivariensis as
Zygosaccharomyces sp. (click for details) |
|
|
|
Mycetoma / Chromoblastomycosis / Paracoccidioidomycosis (click for details) |
|
|
|
Invasive fungal infections in icu (click for details) |
|
|
|
Antifungal activity of the phenolic essential oil of Thymus viciosoi (click for details) |
|
|
|
Tinea capitis in central tunisia: prevalence and etiologic agents over a 30 years period (click for details) |
|
|
|
Pelvic Mucormycosis Refractory to Amphotericin-B in a Young Woman With Good
Response to Posoconazole (click for details) |
|
|
|
Efficacy Outcomes in a Randomized Trial of Liposomal Amphotericin B (L-AMB) Based
on Revised EORTC/MSG 2008 Definitions of Invasive Fungal Disease (IFD) (click for details) |
|
|
|
Oral candidiasis in patients with HIV / AIDS: identification of species and evaluation of
the profile of sensitivity and resistance to antifungal drugs (preliminary results) (click for details) |
|
|
